Stock Information
Mirum Pharmaceuticals Inc (MIRM)
Ticker Symbol: MIRM
Exchange: NASDAQ
Sector: Biotechnology
Market Cap: $6,383.54 mil
Piotroski score: 6
PE Ratio: N/A
EPS (TTM): -0.4783
Revenue (TTM): $10.12 M
Dividend Yield: N/A%
ROE: -8.53%
Latest News
-
TD Cowen Maintains Buy on Mirum Pharmaceuticals, Raises Price Target to $145
Thu, May 7, 2026 3:48 PM
-
RBC Capital Maintains Outperform on Mirum Pharmaceuticals, Raises Price Target to $142
Thu, May 7, 2026 1:47 PM
-
Evercore ISI Group Maintains Outperform on Mirum Pharmaceuticals, Raises Price Target to $138
Thu, May 7, 2026 10:50 AM
-
Baird Maintains Outperform on Mirum Pharmaceuticals, Raises Price Target to $129
Thu, May 7, 2026 7:44 AM
-
Mirum Pharmaceuticals, Inc. (MIRM) Q1 2026 Earnings Call Transcript
Wed, May 6, 2026 11:21 PM
-
Transcript : Mirum Pharmaceuticals, Inc., Q1 2026 Earnings Call, May 06, 2026
Wed, May 6, 2026 11:20 PM
-
Mirum Pharmaceuticals (NASDAQ:MIRM) Stock Dips After Q1 Revenue Beat and Guidance Raise, Despite Massive IPR&D Charge
Wed, May 6, 2026 8:47 PM
-
Mirum Pharmaceuticals, Inc. (MIRM) Discusses Topline Clinical Results in Primary Sclerosing Cholangitis and Hepatitis Delta - Slideshow
Wed, May 6, 2026 7:16 PM
-
UPDATE: Mirum Pharmaceuticals Q1 Adj. EPS $(0.50) Misses $(0.35) Estimate, Sales $159.882M Beat $149.535M Estimate
Wed, May 6, 2026 5:49 PM
-
Earnings Scheduled For May 6, 2026
Wed, May 6, 2026 5:03 PM
Key Financials
Financial data not available
